EDP-721

N/A

Report date: 2025/03/19 16:22:38
NME

Base Information

Drug NameEDP-721
Drug Alias NameEDP-721
ClassificationSmall molecules
Mechanisms of ActionTerminal nucleotidyltransferase 4B inhibitorsTerminal nucleotidyltransferase 4A inhibitors
TargetsTerminal nucleotidyltransferase 4BTerminal nucleotidyltransferase 4A
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew Zealand
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEnanta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnanta Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A